InvesT1D: InvesT1D is a flexible, patient centered financial incentives intervention. A pilot randomized trial demonstrated improvements to adherence to self-management goals and time-in-range among continuous glucose monitor users. In this hybrid, effectiveness-implementation study, we will evaluate InvesT1D’s efficacy, long-term health benefits, cost-effectiveness, and implementation feasibility. The intervention is being evaluated at Seattle Children's Hospital by Drs. Catherine Pihoker, Faisal Malik, and others. More→
Related research products
Adolescent and parent perspectives on the acceptability of financial incentives to promote self-care in adolescents with type 1 diabetes. Pediatr Diabetes, 2020. 📄
Ethically incentivising healthy behaviours: views of parents and adolescents with type 1 diabetes. J Med Ethics, 2020. 📄
Adolescent-preferred financial incentives to promote type 1 diabetes self-care: a discrete choice experiment. Diabetes Res Clin Pract, 2024. 📄
Use of financial incentives to promote adolescent type 1 diabetes self-management: a pilot randomized controlled trial. Diabetes Care, 2024. 📄
Understanding Diabetes Drug Initiation and Offerings (aUDIO): The overall objective of this project is to examine decision making regarding diabetes medication choice. Using a database of recorded diabetes-related clinic visits where use of a novel diabetes medication was discussed, we aim to (1) describe shared decision making practices and (2) characterize strategies used to discuss patient medication out-of-pocket costs. More→
Related research products
I’ll Tell You What I’m Going to Do: Shared Decision Making Practices Regarding GLP 1RA Treatment Choice for Patients with Type 2 Diabetes. Society for Medical Decision Making 48th Annual Meeting, Oslo, Norway, June 28 – July 1, 2026.
“You’ve Probably Seen Them on TV”: GLP 1 Cost and Coverage Discussions in Real-World Type 2 Diabetes Encounters. Society for Medical Decision Making 48th Annual Meeting, Oslo, Norway, June 28 – July 1, 2026.
New Kids on the Block: Qualitative Insights Into Reproductive Planning Amid Emerging Diabetes Treatments. Society for Medical Decision Making 48th Annual Meeting, Oslo, Norway, June 28 – July 1, 2026.
Optimizing Health Insurance Choice for Diabetes (OrCHID): Health plan characteristics influence the ways in which patients use care. Whether enrollment in stated preference-aligned health plans is associated with improved access to care and health outcomes for patients with diabetes is unknown. This study aims to assess the relationship between stated preference-plan enrollment and adverse health outcomes, health care quality, and health care utilization using claims data from a commercial health insurance plan. More→
Related research products [under review]